Financial Year |
March 31 2023 |
Monetary Funds |
839,569,091.13 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
368,622,542.42 |
Advances to Suppliers |
10,798,596.62 |
Other Receivables |
4,454,845.32 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
320,222,014.71 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
27,537,850.73 |
Total Current Assets |
1,586,702,124.31 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
2,019,311,125.02 |
Under-construction Projects |
675,683,074.35 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
190,674,138.78 |
R&D expenses |
-- |
Goodwill |
20,861,686.00 |
Long-Term Deferred and Prepaid Expenses |
11,383,929.56 |
Deferred Income Tax Assets |
29,299,443.16 |
Other Non-Current Assets |
73,605,371.99 |
Sub-Total of Non-Current Assets |
3,094,404,217.77 |
Total Assets |
4,681,106,342.08 |
Short-Term Loans |
508,443,214.85 |
Trading Financial liabilities |
-- |
Notes Payable |
19,500,000.00 |
Accounts Payable |
157,596,336.74 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
23,540,088.22 |
Taxes Payable |
5,773,743.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,914,479.17 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
85,673,244.21 |
Other Current Liabilities |
244,993.71 |
Sub-Total of Current Liabilities |
807,570,666.89 |
Long-term Loans |
354,643,828.28 |
Bonds Payable |
539,827,099.04 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
73,427,316.86 |
Other Non-Current Liabilities |
64,380,740.00 |
Sub-Total of Non-Current Liabilities |
1,060,158,919.90 |
Total Liabilities |
1,867,729,586.79 |
Paid-In Capital(Or Share Stock) |
434,259,336.00 |
Capital Surplus |
975,152,359.06 |
Surplus Reserve |
145,505,898.85 |
LESS:Treasury Stock |
56,380,740.00 |
Undistributed Profits |
1,208,786,500.70 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,813,376,755.29 |
Owner's Equity(Stockholder's Equity) |
2,813,376,755.29 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,681,106,342.08 |